Active Ingredient(s):Naloxegol FDA Approved: * September 16, 2014 Pharm Company: *ASTRAZENECA PHARMS Category:Opioid Dependence
Naloxegol (INN; PEGylated naloxol; trade names Movantik and Moventig) is a peripherally acting μ-opioid receptor antagonist developed by AstraZeneca, licensed from Nektar Therapeutics, for the treatment of opioid-induced constipation. It was approved in 2014 in adult patients with chronic, non-cancer pain. Doses of 25mg were found safe and well tolerated for 52 weeks. When given concomitantly with opioid analgesi...
* May have multiple approval dates, manufacturers, or labelers. 11 Discussions